Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.

Source:http://linkedlifedata.com/resource/pubmed/id/19821799

Download in:

View as

General Info

PMID
19821799